Evaluating Homologous Recombinant Deficiency and Response to Therapy in Patients with Advanced Pancreatic Cancer
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to compare patterns of molecular markers in patients with good response vs. poor response to chemotherapy as determine by response to therapy per RECIST V1.1 and progression free survival (PFS) after diagnosis of metastatic disease.
Description
The purpose of this study is to compare patterns of molecular markers in patients with good response vs. poor response to chemotherapy as determine by response to therapy per RECIST V1.1 and progression free survival (PFS) after diagnosis of metastatic disease.
Details
| Condition | pancreatic cancer |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX5446 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.